Insulin resistance

An early metabolic defect of turner’s syndrome

Sonia Caprio, Susan Boulware, Michael Peter Diamond, Robert S. Sherwin, T. O. Carpenter, Karen Rubin, Stephanie Amiel, Martin Press, William V. Tamborlane

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

To evaluate whether insulin resistance contributes to the increased risk of diabetes in patients with Turner's syndrome, we measured insulin sensitivity (using the euglycemic insulin clamp technique, 40 mU/m2· min) and whole body glucose and lipid oxidation (assessed by indirect calorimetry) in two groups of nondiabetic patients with Turner's syndrome and age-matched normal controls. Group 1 consisted of eight young patients (mean age, 10 ± 0.8 yr) who had never received hormone therapy, and group 2 consisted of five patients (mean age, 17.6 ± 1.4 yr) who had been or were on estrogen therapy. In group 2, [3-3H]glucose was also infused during the euglycemic clamp to assess hepatic sensitivity to insulin. During the euglycemic clamp, insulin-stimulated glucose metabolism was decreased in both groups of patients [group 1, 8.4 ± 1.0 vs. 14.7 ± 2 mM/m2 · min in controls (P < 0.05); group 2, 9 ± 0.7 vs. 11.7 ± 0.9 mm/m2·min in controls (P < 0.05)]. The impairment of insulin-stimulated glucose metabolism in patients with Turner's syndrome was accounted for by reduced nonoxidative glucose disposal; glucose oxidation rose to a similar extent in Turner patients and normal controls. Insulin-induced suppression of hepatic glucose production (group 2) and plasma FFA and branched chain amino acid levels in Turner patients was also indistinguishable from that in normal controls. Our data suggest that in patients with Turner's syndrome, insulin resistance is a very early metabolic defect that may be restricted to nonoxidative pathways of intracellular glucose metabolism.

Original languageEnglish (US)
Pages (from-to)832-836
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume72
Issue number4
DOIs
StatePublished - Jan 1 1991

Fingerprint

Turner Syndrome
Insulin Resistance
Insulin
Glucose
Defects
Clamping devices
Glucose Clamp Technique
Metabolism
Branched Chain Amino Acids
Oxidation
Indirect Calorimetry
Calorimetry
Medical problems
Liver
Group Psychotherapy
Estrogens
Hormones
Lipids
Plasmas

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Caprio, S., Boulware, S., Diamond, M. P., Sherwin, R. S., Carpenter, T. O., Rubin, K., ... Tamborlane, W. V. (1991). Insulin resistance: An early metabolic defect of turner’s syndrome. Journal of Clinical Endocrinology and Metabolism, 72(4), 832-836. https://doi.org/10.1210/jcem-72-4-832

Insulin resistance : An early metabolic defect of turner’s syndrome. / Caprio, Sonia; Boulware, Susan; Diamond, Michael Peter; Sherwin, Robert S.; Carpenter, T. O.; Rubin, Karen; Amiel, Stephanie; Press, Martin; Tamborlane, William V.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 72, No. 4, 01.01.1991, p. 832-836.

Research output: Contribution to journalArticle

Caprio, S, Boulware, S, Diamond, MP, Sherwin, RS, Carpenter, TO, Rubin, K, Amiel, S, Press, M & Tamborlane, WV 1991, 'Insulin resistance: An early metabolic defect of turner’s syndrome', Journal of Clinical Endocrinology and Metabolism, vol. 72, no. 4, pp. 832-836. https://doi.org/10.1210/jcem-72-4-832
Caprio, Sonia ; Boulware, Susan ; Diamond, Michael Peter ; Sherwin, Robert S. ; Carpenter, T. O. ; Rubin, Karen ; Amiel, Stephanie ; Press, Martin ; Tamborlane, William V. / Insulin resistance : An early metabolic defect of turner’s syndrome. In: Journal of Clinical Endocrinology and Metabolism. 1991 ; Vol. 72, No. 4. pp. 832-836.
@article{9ac5366bc06f46dababf7db457bcb460,
title = "Insulin resistance: An early metabolic defect of turner’s syndrome",
abstract = "To evaluate whether insulin resistance contributes to the increased risk of diabetes in patients with Turner's syndrome, we measured insulin sensitivity (using the euglycemic insulin clamp technique, 40 mU/m2· min) and whole body glucose and lipid oxidation (assessed by indirect calorimetry) in two groups of nondiabetic patients with Turner's syndrome and age-matched normal controls. Group 1 consisted of eight young patients (mean age, 10 ± 0.8 yr) who had never received hormone therapy, and group 2 consisted of five patients (mean age, 17.6 ± 1.4 yr) who had been or were on estrogen therapy. In group 2, [3-3H]glucose was also infused during the euglycemic clamp to assess hepatic sensitivity to insulin. During the euglycemic clamp, insulin-stimulated glucose metabolism was decreased in both groups of patients [group 1, 8.4 ± 1.0 vs. 14.7 ± 2 mM/m2 · min in controls (P < 0.05); group 2, 9 ± 0.7 vs. 11.7 ± 0.9 mm/m2·min in controls (P < 0.05)]. The impairment of insulin-stimulated glucose metabolism in patients with Turner's syndrome was accounted for by reduced nonoxidative glucose disposal; glucose oxidation rose to a similar extent in Turner patients and normal controls. Insulin-induced suppression of hepatic glucose production (group 2) and plasma FFA and branched chain amino acid levels in Turner patients was also indistinguishable from that in normal controls. Our data suggest that in patients with Turner's syndrome, insulin resistance is a very early metabolic defect that may be restricted to nonoxidative pathways of intracellular glucose metabolism.",
author = "Sonia Caprio and Susan Boulware and Diamond, {Michael Peter} and Sherwin, {Robert S.} and Carpenter, {T. O.} and Karen Rubin and Stephanie Amiel and Martin Press and Tamborlane, {William V.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1210/jcem-72-4-832",
language = "English (US)",
volume = "72",
pages = "832--836",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Insulin resistance

T2 - An early metabolic defect of turner’s syndrome

AU - Caprio, Sonia

AU - Boulware, Susan

AU - Diamond, Michael Peter

AU - Sherwin, Robert S.

AU - Carpenter, T. O.

AU - Rubin, Karen

AU - Amiel, Stephanie

AU - Press, Martin

AU - Tamborlane, William V.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - To evaluate whether insulin resistance contributes to the increased risk of diabetes in patients with Turner's syndrome, we measured insulin sensitivity (using the euglycemic insulin clamp technique, 40 mU/m2· min) and whole body glucose and lipid oxidation (assessed by indirect calorimetry) in two groups of nondiabetic patients with Turner's syndrome and age-matched normal controls. Group 1 consisted of eight young patients (mean age, 10 ± 0.8 yr) who had never received hormone therapy, and group 2 consisted of five patients (mean age, 17.6 ± 1.4 yr) who had been or were on estrogen therapy. In group 2, [3-3H]glucose was also infused during the euglycemic clamp to assess hepatic sensitivity to insulin. During the euglycemic clamp, insulin-stimulated glucose metabolism was decreased in both groups of patients [group 1, 8.4 ± 1.0 vs. 14.7 ± 2 mM/m2 · min in controls (P < 0.05); group 2, 9 ± 0.7 vs. 11.7 ± 0.9 mm/m2·min in controls (P < 0.05)]. The impairment of insulin-stimulated glucose metabolism in patients with Turner's syndrome was accounted for by reduced nonoxidative glucose disposal; glucose oxidation rose to a similar extent in Turner patients and normal controls. Insulin-induced suppression of hepatic glucose production (group 2) and plasma FFA and branched chain amino acid levels in Turner patients was also indistinguishable from that in normal controls. Our data suggest that in patients with Turner's syndrome, insulin resistance is a very early metabolic defect that may be restricted to nonoxidative pathways of intracellular glucose metabolism.

AB - To evaluate whether insulin resistance contributes to the increased risk of diabetes in patients with Turner's syndrome, we measured insulin sensitivity (using the euglycemic insulin clamp technique, 40 mU/m2· min) and whole body glucose and lipid oxidation (assessed by indirect calorimetry) in two groups of nondiabetic patients with Turner's syndrome and age-matched normal controls. Group 1 consisted of eight young patients (mean age, 10 ± 0.8 yr) who had never received hormone therapy, and group 2 consisted of five patients (mean age, 17.6 ± 1.4 yr) who had been or were on estrogen therapy. In group 2, [3-3H]glucose was also infused during the euglycemic clamp to assess hepatic sensitivity to insulin. During the euglycemic clamp, insulin-stimulated glucose metabolism was decreased in both groups of patients [group 1, 8.4 ± 1.0 vs. 14.7 ± 2 mM/m2 · min in controls (P < 0.05); group 2, 9 ± 0.7 vs. 11.7 ± 0.9 mm/m2·min in controls (P < 0.05)]. The impairment of insulin-stimulated glucose metabolism in patients with Turner's syndrome was accounted for by reduced nonoxidative glucose disposal; glucose oxidation rose to a similar extent in Turner patients and normal controls. Insulin-induced suppression of hepatic glucose production (group 2) and plasma FFA and branched chain amino acid levels in Turner patients was also indistinguishable from that in normal controls. Our data suggest that in patients with Turner's syndrome, insulin resistance is a very early metabolic defect that may be restricted to nonoxidative pathways of intracellular glucose metabolism.

UR - http://www.scopus.com/inward/record.url?scp=0025825014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025825014&partnerID=8YFLogxK

U2 - 10.1210/jcem-72-4-832

DO - 10.1210/jcem-72-4-832

M3 - Article

VL - 72

SP - 832

EP - 836

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -